RxDoctor Payments Data
★ My doctorsLook up a doctor →

Rae Hornsby

Developmental - Behavioral Pediatrics · Greenville, SCNPI 1518917061

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 262 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by Ironshore Pharmaceuticals Inc. at 28.1% of the total. Reporting peaked in 2023 at $1,070 and has fallen 61.2% since, to $415 in 2025.

$4,105in general payments, 2019–2025

Across 262 payments — averaging $15.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Ironshore Pharmaceuticals Inc.$1K
  • Supernus Pharmaceuticals, Inc.$936
  • Tris Pharma Inc$631
  • Corium, LLC$608
  • Neos Therapeutics, LP$200
  • Takeda Pharmaceuticals U.S.A., Inc.$181
  • plus $397 from 10 others

What the payments were for

  • Food & beverage$4,105100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Ironshore Pharmaceuticals Inc.75$1,152
Supernus Pharmaceuticals, Inc.71$936
Tris Pharma Inc41$631
Corium, LLC31$608
Neos Therapeutics, LP11$200
Takeda Pharmaceuticals U.S.A., Inc.9$181
Adlon Therapeutics L.p.5$76
Collegium Pharmaceutical, Inc.4$70
Noven Therapeutics, LLC3$67
Idorsia Pharmaceuticals US Inc4$66
Rhodes Pharmaceuticals L.p.2$37
Shire North American Group Inc2$24
Aytu Biopharma, Inc.1$17
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)1$17
Arbor Pharmaceuticals, Inc.1$13
Vertical Pharmaceuticals, LLC1$12

How this compares

Too few developmental - behavioral pediatrics providers in South Carolinato place this figure against a meaningful peer group, so we don't.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fluoxetine Hcl11$1,395
Guanfacine Hcl ErGuanfacine Hcl12$215

Paid to pharmacies, not to this prescriber.

Other developmental - behavioral pediatrics in Greenville

See the full list for South Carolina →

Where these figures come from

Is this you, or does something look wrong? →